Description of key strategic decisions facing the scientific founder and CEO of promising early stage bio-pharmaceutical company company.l should establish the proposed alliance with the pharmaceutical company? Whether it should create a nutraceuticals business in parallel to its efforts to develop an anti-aging treatment? And if he is licensed second candidate for drug development? “Hide
by Toby Stuart, David Kiron Source: Harvard Business School 24 pages. Publication Date: March 20, 2008. Prod. #: 808112-PDF-ENG
Message from CEO TheCaseSolutions.com
We live and breathe case studies and solve every case study from scratch. All of our writers are in-house full time employees. This gives us an indomitable competitive advantage through our Economies of Scale (affordable prices) and Direct Control (which allows quality end-product delivery). Other academic writing companies relying on freelancers simply cannot compete with us
Sound good? Click "I'M READY" to get started right away.